Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for INSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 28.91M
March 31, 2026 28.80M
December 31, 2025 28.58M
September 30, 2025 29.05M
June 30, 2025 29.57M
March 31, 2025 29.47M
December 31, 2024 29.74M
September 30, 2024 29.96M
June 30, 2024 29.81M
March 31, 2024 29.68M
December 31, 2023 29.56M
September 30, 2023 29.40M
June 30, 2023 29.33M
March 31, 2023 29.16M
December 31, 2022 29.01M
September 30, 2022 28.82M
June 30, 2022 27.63M
March 31, 2022 27.57M
December 31, 2021 27.42M
September 30, 2021 27.35M
June 30, 2021 27.26M
Date Value
March 31, 2021 27.20M
December 31, 2020 27.07M
September 30, 2020 26.92M
June 30, 2020 26.75M
March 31, 2020 24.36M
December 31, 2019 24.11M
September 30, 2019 24.04M
June 30, 2019 23.90M
March 31, 2019 23.50M
December 31, 2018 23.40M
September 30, 2018 21.39M
June 30, 2018 21.35M
March 31, 2018 21.30M
December 31, 2017 21.25M
September 30, 2017 21.25M
June 30, 2017 21.25M
March 31, 2017 21.25M
December 31, 2016 21.25M
September 30, 2016 21.25M
June 30, 2016 21.25M
March 31, 2016 21.25M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Intuitive Surgical, Inc. 353.90M
Globus Medical, Inc. 134.25M
Enovis Corp. 57.67M
Inogen, Inc. 26.73M
Solventum Corp. 170.11M